𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model

✍ Scribed by M. Roggendorf; I. Schulte; Y. Xu; M. Lu


Book ID
108886068
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
152 KB
Volume
14
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Antiviral activity and toxicity of fialu
✍ Bud C. Tennant; Betty H. Baldwin; Lou Ann Graham; Mary A. Ascenzi; William E. Ho πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 645 KB

Woodchucks were used to study the antiviral activity and toxicity of fialuridine (FIAU; 1,-2'deoxy-2'fluoro-1-beta-D-arabinofuranosyl-5-iodo-uracil). In an initial experiment, groups of six chronic woodchuck hepatitis virus (WHV) carrier woodchucks received daily doses of FIAU by intraperitoneal inj

Characterization of woodchuck apolipopro
✍ Jessica Fioravanti; Celia Gomar; JosΓ© Medina-Echeverz; Itziar Otano; Alberto Ben πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 560 KB

## Abstract Apolipoprotein A‐I (ApoA‐I) is the major protein component of high density lipoprotein (HDL) particles in serum, and participates in the reverse transport of cholesterol from tissues to the liver for excretion. The natural HDL tropism to the liver and cancer cells has been used extensiv

Cytokine-dependent anti-viral role of CD
✍ Fenyu Ren; Keisuke Hino; Yuhki Yamaguchi; Kiyomi Funatsuki; Akio Hayashi; Hiroak πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 210 KB

## Abstract There are several lines of evidence suggesting that specific vaccine therapy with a standard hepatitis B virus (HBV) vaccination reduces HBV replication. The aim of this study was to investigate the anti‐viral mechanism of vaccine therapy in chronic hepatitis B patients. Nineteen patien

Efficacy of hepatitis B vaccine against
✍ Saleem Kamili; Vitini Sozzi; Geoff Thompson; Katie Campbell; Christopher M. Walk πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 579 KB

Hepatitis B virus (HBV) mutants resistant to treatment with nucleoside or nucleotide analogs and those with the ability to escape from HBV-neutralizing antibody have the potential to infect HBV-vaccinated individuals. To address this potential serious public health challenge, we tested the efficacy